×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Hoberman Kenneth

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
NVCTNuvectis Pharma, Inc.Hoberman KennethDirectorMay 12, 2022Buy$17.406,000104,40055,140May 16, 2022, 08:33 AM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerMar 09, 2020Sale$5.089,48748,194788,468Mar 13, 2020, 09:31 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerMar 10, 2020Sale$4.9116,70482,017771,764Mar 13, 2020, 09:31 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerFeb 25, 2020Sale$6.4211,54774,132797,955Feb 28, 2020, 09:31 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerJan 22, 2020Sale$7.0222,139155,416601,085Jan 24, 2020, 09:31 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerJan 08, 2020Sale$10.3713,228137,174623,224Jan 10, 2020, 09:16 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerDec 26, 2019Sale$10.7515,494166,561638,474Jan 03, 2020, 05:19 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerDec 27, 2019Sale$10.482,02221,191636,452Jan 03, 2020, 05:19 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerDec 23, 2019Sale$10.584,31945,695678,445Jan 03, 2020, 05:19 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerDec 24, 2019Sale$10.9724,477268,513653,968Jan 03, 2020, 05:19 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerJun 24, 2019Sale$15.499,107141,067720,772Jun 28, 2019, 05:17 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerJun 25, 2019Sale$15.0725,500384,285695,272Jun 28, 2019, 05:17 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerJun 26, 2019Sale$14.7712,508184,743682,764Jun 28, 2019, 05:17 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerMay 14, 2019Sale$14.2725,817368,409729,879May 17, 2019, 09:29 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerMar 11, 2019Sale$11.1125,101278,872756,677Mar 15, 2019, 09:00 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerMar 12, 2019Sale$11.0498110,830755,696Mar 15, 2019, 09:00 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerMar 07, 2019Sale$11.362,99534,023781,778Mar 08, 2019, 09:31 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerFeb 25, 2019Sale$12.0510,557127,212784,773Feb 27, 2019, 09:10 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerJan 08, 2019Sale$10.1513,547137,502646,652Jan 11, 2019, 09:30 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerNov 26, 2018Sale$11.8526,296311,608659,738Nov 30, 2018, 08:59 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerMar 12, 2018Sale$17.3817,241299,697425,639Mar 14, 2018, 09:30 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerMar 13, 2018Sale$16.8212,746214,388409,594Mar 14, 2018, 09:30 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerMar 07, 2018Sale$16.553,02750,097369,278Mar 09, 2018, 09:32 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerFeb 27, 2018Sale$17.265,72698,831371,915Feb 28, 2018, 09:31 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerFeb 26, 2018Sale$17.615,30093,333377,641Feb 28, 2018, 09:31 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerFeb 15, 2018Sale$15.671,85129,005382,941Feb 16, 2018, 09:31 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerJan 08, 2018Sale$13.9314,040195,577384,792Jan 12, 2018, 09:31 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerDec 15, 2017Sale$14.1811,943169,352398,872Dec 19, 2017, 07:58 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerDec 18, 2017Sale$14.7540590398,832Dec 19, 2017, 07:58 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerMar 07, 2017Sale$8.162,34219,111277,674Mar 09, 2017, 09:33 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerFeb 27, 2017Sale$6.974,00027,880283,682Mar 01, 2017, 09:53 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerFeb 28, 2017Sale$7.014,02728,229279,655Mar 01, 2017, 09:53 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerFeb 16, 2017Sale$6.421,5089,681287,682Feb 17, 2017, 09:03 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerJan 10, 2017Sale$13.829,110125,900289,190Jan 13, 2017, 08:01 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerMar 08, 2016Sale$5.342,41212,880297,392Mar 10, 2016, 08:57 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerFeb 17, 2016Sale$4.541,5036,824211,059Feb 19, 2016, 09:01 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerMar 19, 2015Option Exercise$8.9044,412395,213139,426Mar 20, 2015, 04:17 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerFeb 18, 2015Sale$14.021,59322,33487,942Feb 20, 2015, 05:43 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerSep 02, 2014Buy$10.992,00021,97589,535Sep 03, 2014, 02:48 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerMay 21, 2014Sale$13.3215,250203,13087,535May 23, 2014, 04:54 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerNov 22, 2013Sale$5.8246,523270,92354,288Nov 27, 2013, 08:22 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerNov 25, 2013Sale$6.9351,350355,90979,765Nov 27, 2013, 08:22 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerNov 26, 2013Sale$7.3810,11174,60672,382Nov 27, 2013, 08:22 PM
STMLSTEMLINE THERAPEUTICS INCHoberman KennethChief Operating OfficerNov 27, 2013Option Exercise$6.9849,384344,543103,211Nov 27, 2013, 08:22 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe